Since 2002, CSIRO in Australia has been working on the production of a novel bioactive feed ingredient which not only has been demonstrated to increase growth rate in shrimp from between 20 to 40%, and provide protection to some known pathogens but can also reduce dependence on expensive and potentially unsustainable marine resources. This ingredient called NovacqTM is soon to be commercialized for inclusion into shrimp diets. The Australian feed company Ridley Aqua-Feed, which has commercialization rights in Australia and some SE Asian countries, is now embarking on the next stage of this exciting project.
This presentation describes NovacqTM , summarizes the results obtained when incorporating it into shrimp diets under both laboratory and commercial conditions, outlines the challenging path to commercialization of the product into the global shrimp culture industry and the game changing implications this could have on the sustainability of the industry into the future.
Dr. Matthew Briggs, Technical Project Manager – Novacq Commercialization, Ridley AgriProducts Pty. Ltd., Australia
Matthew Briggs has 30 years aquaculture experience and a PhD in shrimp culture from the Institute of Aquaculture, Scotland.
He has worked worldwide in research, development, training and managing shrimp breeding, larval rearing and grow-out projects for international NGOs (including FAO & NACA) and private companies.
Currently he is employed by Ridley AgriProducts in Australia, working with CSIRO as Technical Project Manager of the NovacqTM (biofloc meal) commercialization project.
He was Director of Vannamei 101 Thailand, as consultant and trainer on shrimp breeding, hatchery and grow-out projects, product and broodstock/PL sales for the past decade.